DUBLIN, IRELAND--(Marketwired - May 4, 2015) - Horizon Pharma plc (
- Bank of America Merrill Lynch 2015 Health Care Conference
- Presentation Date: Tuesday, May 12, 2015
-
Presentation Time: 4:20 p.m. PT (7:20 p.m. ET)
- 2015 UBS Global Health Care Conference
- Presentation Date: Monday, May 18, 2015
-
Presentation Time: 1:00 p.m. ET
The presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.
About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The company markets a portfolio of products in arthritis, inflammation and orphan diseases. The company's U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS® (ibuprofen/famotidine), PENNSAID® (diclofenac sodium topical solution) 2% w/w, RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole magnesium). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.